Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial

Kohei Kaku; Eiichi Araki; Yukio Tanizawa; Bue Ross Agner; Tomoyuki Nishida; Mattis Ranthe; Nobuya Inagaki

doi:10.1111/dom.13856

Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13856 ◽

2019 ◽

Vol 21 (12) ◽

pp. 2674-2683 ◽

Cited By ~ 4

Author(s):

Kohei Kaku ◽

Eiichi Araki ◽

Yukio Tanizawa ◽

Bue Ross Agner ◽

Tomoyuki Nishida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy

Download Full-text

Author response for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v2/response1 ◽

2019 ◽

Author(s):

Kohei Kaku ◽

Eiichi Araki ◽

Yukio Tanizawa ◽

Bue Ross Agner ◽

Tomoyuki Nishida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Author Response ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v2/review3 ◽

2019 ◽

Author(s):

Yoshifumi Saisho

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v1/review3 ◽

2019 ◽

Author(s):

Johan Jendle

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Decision letter for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v2/review4 ◽

2019 ◽

Author(s):

Junichiro Irie

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Decision letter for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v1/review5 ◽

2019 ◽

Author(s):

Junichiro Irie

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text

Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial"

10.1111/dom.13856/v1/review4 ◽

2019 ◽

Author(s):

Yoshio Nagai

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Open Label ◽

Phase 3 ◽

Superior Efficacy ◽

Japanese Subjects

Download Full-text